News – Page 422 – Endpoints News

Sumitovant subsidiaries Enzyvant and Altavant merge into combined company

3 years ago

European Commission lays groundwork to unwind Illumina's $7B+ Grail merger

3 years ago

US supports extension for Covid-19 IP waiver decision

3 years ago

Q&A: Bristol Myers' Kristen Hege on cell therapy, cancer patients and mentoring the next generation

3 years ago

MarketingRx roundup: Pharmas lay off Twitter ads for another week; WPP uncovers LGBTQ+ marketing findings

3 years ago

Bouncing from major setback, Summit hands out $500M cash for cancer drug — thanks to a loan from billionaire CEO

3 years ago

Editas reports early-stage data from two patients in sickle cell disease

3 years ago

AbbVie puts up $40M to license a treatment from HotSpot Therapeutics

3 years ago

Compugen touts ovarian cancer data in combo with Opdivo, anti-TIGIT from ex-partner Bristol Myers

3 years ago

Scoop: Avalon, MPM back new CNS biotech with scientific chops from Astellas

3 years ago

As FDA door shuts on its PI3K, MEI Pharma throws in the towel, lays off staff

3 years ago

Gossamer’s Faheem Hasnain defends a round of positive PAH data as a clear win. But can these PhII results stand up ...

3 years ago

Avalon Ventures spins off a separate fund to handle life science companies — armed with $135M

3 years ago

A new Vega enters the galaxy with bleeding disorder antibody set for 2023 trial

3 years ago

Entact Bio makes its Series A debut with $81M to launch protein enhancement platform

3 years ago

In search for next-gen Covid treatment, Pfizer taps tiny biotech for research deal

3 years ago

Innoforce opens new manufacturing site in China

3 years ago

FDA grants orphan drug designation to Algernon's ifenprodil, while exclusivity remains unclear

3 years ago

Pfizer makes another billion-dollar investment in Europe and expands again in Michigan

3 years ago

‘Catchy’ design tops big ad buys online for grabbing oncologists’ attention — survey

3 years ago

Novartis bolsters Pluvicto's case in prostate cancer with PhIII results

3 years ago

And then there were two: Janssen bows out of Horizon takeover negotiations

3 years ago

Nkarta underscores safety of CAR-NK, boasts early responses

3 years ago

Pfizer-backed Mediar Therapeutics ropes in another Big Pharma investor

3 years ago

First page Previous page 419 420 421422423 424 425 Next page Last page